Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation.
Hayakawa J, Miyamura D, Kimura SI, Gomyo A, Tamaki M, Akahoshi Y, Harada N, Ugai T, Kusuda M, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Kanda Y. Hayakawa J, et al. Bone Marrow Transplant. 2019 Jul;54(7):994-1003. doi: 10.1038/s41409-018-0365-4. Epub 2018 Oct 18. Bone Marrow Transplant. 2019. PMID: 30337699
Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation.
Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako-Saito K, Kimura S, Nakasone H, Kikuchi M, Yamazaki R, Kanda J, Kako S, Nishida J, Tsunoda H, Omori Y, Nakazawa M, Tanaka O. Kanda Y, et al. Ann Hematol. 2014 Feb;93(2):287-92. doi: 10.1007/s00277-013-1852-8. Epub 2013 Jul 28. Ann Hematol. 2014. PMID: 23892927 Clinical Trial.
Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Sakamoto K, et al. PLoS One. 2013 Sep 5;8(9):e73754. doi: 10.1371/journal.pone.0073754. eCollection 2013. PLoS One. 2013. PMID: 24040054 Free PMC article.
Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Tanaka Y, et al. Immunol Lett. 2014 Mar-Apr;158(1-2):120-5. doi: 10.1016/j.imlet.2013.12.016. Epub 2014 Jan 2. Immunol Lett. 2014. PMID: 24389072
Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts.
Nakasone H, Terasako-Saito K, Yamazaki R, Sato M, Tanaka Y, Sakamoto K, Kurita M, Yamasaki R, Wada H, Ishihara Y, Kawamura K, Machishima T, Ashizawa M, Kimura S, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Yamada S, Kanda Y. Nakasone H, et al. Exp Hematol. 2014 Apr;42(4):261-73. doi: 10.1016/j.exphem.2013.12.009. Epub 2014 Jan 7. Exp Hematol. 2014. PMID: 24407161 Free article. Clinical Trial.
Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.
Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Kimura SI, Kikuchi M, Tanihara A, Kanda J, Kako S, Nishida J, Kanda Y. Sato M, et al. Bone Marrow Transplant. 2014 Apr;49(4):553-60. doi: 10.1038/bmt.2013.217. Epub 2014 Jan 13. Bone Marrow Transplant. 2014. PMID: 24419514
Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.
Kimura S, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Nakasone H, Kikuchi M, Yamazaki R, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Kimura S, et al. J Infect. 2014 Jul;69(1):13-25. doi: 10.1016/j.jinf.2014.02.013. Epub 2014 Feb 26. J Infect. 2014. PMID: 24583063 Review.
Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.
Kawamura K, Yamazaki R, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y. Kawamura K, et al. Hematology. 2015 Mar;20(2):77-82. doi: 10.1179/1607845414Y.0000000174. Epub 2014 Jul 3. Hematology. 2015. PMID: 24992512 Free article.
Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia.
Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y. Ishihara Y, et al. Int J Hematol. 2014 Dec;100(6):607-10. doi: 10.1007/s12185-014-1650-7. Epub 2014 Aug 13. Int J Hematol. 2014. PMID: 25115834
Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y. Kikuchi M, et al. J Chemother. 2015 Feb;27(2):99-105. doi: 10.1179/1973947814Y.0000000219. Epub 2014 Oct 14. J Chemother. 2015. PMID: 25314911
57 results